Holen Sie sich die Stockscreener-App
1.01
3.35%
-0.035
Schlusskurs vom Vortag:
$1.045
Offen:
$1.06
24-Stunden-Volumen:
2.20M
Relative Volume:
57.26
Marktkapitalisierung:
$3.17M
Einnahmen:
$482.00K
Nettoeinkommen (Verlust:
$-7.51M
KGV:
-0.1083
EPS:
-9.327
Netto-Cashflow:
$-6.63M
1W Leistung:
+0.00%
1M Leistung:
+0.00%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$0.9201
$1.06
1-Wochen-Bereich:
$0.8736
$1.09
52-Wochen-Spanne:
$0.8736
$1.09
Valion Bio Inc Stock (VBIO) Company Profile
Firmenname
Valion Bio Inc
Sektor
Branche
Telefon
(888)276-6888
Adresse
1305 E. HOUSTON STREET, SAN ANTONIO
Compare VBIO vs MOBBW, GOODO, SHMD, PSNYW, DWLD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| 0.00 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
2.485 | 3.30B | 0 | 0 | 0 | 0.00 |
GOODO
Gladstone Commercial Corporation
|
20.13 | 372.90M | 0 | 0 | 0 | 0.00 |
SHMD
Schmid Group N V
|
5.29 | 305.77M | 52.15M | -21.46M | 0 | -0.4675 |
PSNYW
Polestar Automotive Holding Uk
|
3.09 | 285.84M | 2.07B | -1.42B | -1.37B | -0.6765 |
DWLD
Davis Select Worldwide ETF
|
47.06 | 0 | 0 | 0 | 0 | 0.00 |
Valion Bio Inc Aktie (VBIO) Neueste Nachrichten
Valion Bio Appoints Melinda Lackey as General Counsel - The Globe and Mail
symbol__ Stock Quote Price and Forecast - CNN
Valion Bio Names Melinda Lackey General Counsel as It Advances Immunotherapy Pipeline and Regulatory Strategy - citybiz
Valion Bio receives protocol for radiation syndrome drug study - Investing.com
Valion Bio receives first FDA-precedent study protocol from NIAID for Entolimod; federal agency to fully fund BLA-enabling in vivo program and co-navigate FDA submission - marketscreener.com
Valion Bio receives protocol for radiation syndrome drug study By Investing.com - Investing.com Canada
VALION BIO RECEIVES FIRST FDA-PRECEDENT STUDY PROTOCOL FROM NIAID FOR ENTOLIMOD™; FEDERAL AGENCY TO FULLY FUND BLA-ENABLING IN VIVO PROGRAM AND CO-NAVIGATE FDA SUBMISSION - Morningstar
Valion Bio Taps Legal-Science Hybrid to Drive Growth Strategy - BriefGlance
Valion Bio (VBIO) grants 45,000 stock options to general counsel - Stock Titan
Valion Bio (VBIO) General Counsel Melinda Lackey becomes reporting insider with Form 3 - Stock Titan
Valion Bio (Nasdaq: VBIO) hires Melinda Lackey as General Counsel - Stock Titan
VBIO Price Today: Valion Bio, Inc. Stock Price, Quote & Chart - MEXC
VBIO | Valion Bio, Inc. Common Insider Trading - Quiver Quantitative
VBIO | Valion Bio, Inc. Common Institutional Ownership - Quiver Quantitative
VBIO | Valion Bio, Inc. Common Stock Data, Price & News - Quiver Quantitative
[ARS] Tivic Health Systems, Inc. SEC Filing - Stock Titan
Valion Bio (TIVC) seeks approval for equity plan, financings and 2026 board vote - Stock Titan
VBIO Price Today: Valion Bio, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
Number of employees of Valion Bio, Inc. – NASDAQ:VBIO - TradingView
Valion Bio, Inc.: Shareholders Board Members Managers and Company Profile | US8887053085 - marketscreener.com
Valion Bio, Inc.: Performance & Quotes, VBIO Stock Price on Nasdaq Exchange - marketscreener.com
Free float of Valion Bio, Inc. – NASDAQ:VBIO - TradingView
Total liabilities of Valion Bio, Inc. – NASDAQ:VBIO - TradingView
Valion Bio, Inc. Balance Sheet – NASDAQ:VBIO - TradingView
EBITDA margin % of Valion Bio, Inc. – NASDAQ:VBIO - TradingView
Return on equity % of Valion Bio, Inc. – NASDAQ:VBIO - TradingView
Valion Bio, Inc. Statistics – NASDAQ:VBIO - TradingView
CapEx per share of Valion Bio, Inc. – NASDAQ:VBIO - TradingView
Inventory turnover of Valion Bio, Inc. – NASDAQ:VBIO - TradingView
Total equity of Valion Bio, Inc. – NASDAQ:VBIO - TradingView
Valion Bio, Inc. Dividends – NASDAQ:VBIO - TradingView
Valion Bio, Inc. Revenue Breakdown – NASDAQ:VBIO - TradingView
EBITDA of Valion Bio, Inc. – NASDAQ:VBIO - TradingView
Valion Bio, Inc. Income Statement – NASDAQ:VBIO - TradingView
Operating income of Valion Bio, Inc. – NASDAQ:VBIO - TradingView
Valion Bio, Inc. Financial Statements – NASDAQ:VBIO - TradingView
EBITDA per share of Valion Bio, Inc. – NASDAQ:VBIO - TradingView
Return on assets % of Valion Bio, Inc. – NASDAQ:VBIO - TradingView
Net income of Valion Bio, Inc. – NASDAQ:VBIO - TradingView
Basic earnings per share (basic EPS) of Valion Bio, Inc. – NASDAQ:VBIO - TradingView
Long term debt to total equity ratio of Valion Bio, Inc. – NASDAQ:VBIO - TradingView
Enterprise value to EBITDA ratio of Valion Bio, Inc. – NASDAQ:VBIO - TradingView
Current ratio of Valion Bio, Inc. – NASDAQ:VBIO - TradingView
Debt to equity ratio of Valion Bio, Inc. – NASDAQ:VBIO - TradingView
Working capital per share of Valion Bio, Inc. – NASDAQ:VBIO - TradingView
Book value per share of Valion Bio, Inc. – NASDAQ:VBIO - TradingView
Price to cash flow ratio of Valion Bio, Inc. – NASDAQ:VBIO - TradingView
Net current asset value per share of Valion Bio, Inc. – NASDAQ:VBIO - TradingView
Quick ratio of Valion Bio, Inc. – NASDAQ:VBIO - TradingView
Debt to assets ratio of Valion Bio, Inc. – NASDAQ:VBIO - TradingView
Operating margin % of Valion Bio, Inc. – NASDAQ:VBIO - TradingView
Finanzdaten der Valion Bio Inc-Aktie (VBIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.14%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):